An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          Grants & Funding: The NIAMS Extramural Program
          Scleroderma, Fibrosis, and Autoinflammatory Disease Program








Scleroderma, Fibrosis, and Autoinflammatory Disease Program FacebookEmailPrintFacebookEmail
        Scleroderma Hero Image

        Overview
              
            This program supports basic, translational, observational, and clinical studies on scleroderma, fibrosis, and autoinflammatory diseases.
Scleroderma is an autoimmune rheumatic disease without an available curative therapy. It is a heterogenous and complex disease that can be categorized as localized scleroderma (morphea) and systemic scleroderma. While etiology of scleroderma is poorly understood, abnormal vasculature, inflammation, and fibrosis are main characteristics of the disease with diverse clinical manifestations (e.g. Raynaud’s phenomenon, digital ulcers, fibrosis in skin and internal organs). Fibrosis is an exaggerated wound healing process which is characterized by a progressive scarring and hardening of tissues with excessive deposition of extracellular matrix. This program supports research on scleroderma, fibrotic diseases, and fibrotic comorbidities associated with rheumatic diseases (e.g. Interstitial lung disease).
Another axis of this program lies on research on the autoinflammatory and inflammasome-mediated diseases characterized by defect(s) or dysregulation on the predominantly innate immune system or inflammasome activity (e.g. gout, juvenile idiopathic arthritis, spondyloarthropathies).
Within each of these portfolio areas, studies could emphasize, but are not limited to, any of the following:

Molecular and cellular mechanisms of pathogenesis and pathophysiology
	Identification of unique genomic, epigenomic, and proteomic signatures
	Immune cells or non-immune cells (e.g. fibroblasts, endothelium, pericytes, and adipocytes) or cross-talk among different cell types leading to impaired inflammation resolution, acute and chronic inflammation, and fibrosis
	Development of animal and organoid models
	Translational and observational and clinical research (e.g. development of diagnosis and therapy, establishment of patient registry and biorepository)

            Contact Us
            Heiyoung Park, Ph.D.
      
  


            Program Director
      
6701 Democracy Boulevard
      
  


            Building: Democracy I, Suite 800
      
Bethesda

      MD

      20892-4872

parkh1@mail.nih.gov
            
    
      301-594-3507     
    FacebookEmailPrintFacebookEmail
        Last Updated: September 2020
 About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
        Subscribe to Our E-Newsletters
            Click the button to see different options to sign up for newsletters.
            Click Here to Subscribe
          Follow us on
  
  About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy Back to Top